Merck (MRK) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $145.19, -1.48% vs the prior close of $147.37.
- Volume 13.85M shares, 1.4x its 50-day average.
- New SEC filings: 25-NSE (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
MRK dips 1.5% to $145.19. Closed at $145.19, -1.48% vs the prior close of $147.37. Day range $144.91–$152.34, opened at $149.70.
MRK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MRK dips 1.5% to $145.19
- Closed at $145.19, -1.48% vs the prior close of $147.37. Day range $144.91–$152.34, opened at $149.70.
- Volume was 13.85M shares, 1.4x its 50-day average of 10.05M.
- Price is +0.3% vs its 50-day average ($144.77) and +16.5% vs its 200-day average ($124.67).
- 52-week range $82.01–$156.92; today's close sits at 84% of that range, 7.5% below the 52-week high.
Oct 14, 2026 — MRK jumps 3.8% to $147.37
- Closed at $147.37, +3.80% vs the prior close of $141.98. Day range $142.66–$148.16, opened at $143.10.
- Volume was 9.80M shares, 1.0x its 50-day average of 10.09M.
- Price is +2.0% vs its 50-day average ($144.43) and +18.4% vs its 200-day average ($124.48).
- 52-week range $82.01–$156.92; today's close sits at 87% of that range, 6.1% below the 52-week high.
Oct 13, 2026 — MRK dips 2.4% to $141.98
- Closed at $141.98, -2.39% vs the prior close of $145.45. Day range $141.58–$145.93, opened at $145.85.
- Volume was 8.38M shares, 0.8x its 50-day average of 10.14M.
- Price is -1.4% vs its 50-day average ($144.05) and +14.2% vs its 200-day average ($124.28).
- 52-week range $82.01–$156.92; today's close sits at 80% of that range, 9.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — MRK ends flat (-0.1%) to $145.45
- Closed at $145.45, -0.10% vs the prior close of $145.60. Day range $144.64–$146.36, opened at $145.75.
- Volume was 8.02M shares, 0.8x its 50-day average of 10.14M.
- Price is +1.2% vs its 50-day average ($143.76) and +17.2% vs its 200-day average ($124.10).
- 52-week range $82.01–$156.92; today's close sits at 85% of that range, 7.3% below the 52-week high.
Oct 9, 2026 — MRK rises 2.3% to $145.60
- Closed at $145.60, +2.26% vs the prior close of $142.38. Day range $141.36–$146.68, opened at $141.37.
- Volume was 9.29M shares, 0.9x its 50-day average of 10.11M.
- Price is +1.5% vs its 50-day average ($143.46) and +17.5% vs its 200-day average ($123.90).
- 52-week range $82.01–$156.92; today's close sits at 85% of that range, 7.2% below the 52-week high.
Oct 8, 2026 — MRK ends flat (-0.3%) to $142.38
- Closed at $142.38, -0.29% vs the prior close of $142.79. Day range $138.89–$142.77, opened at $141.90.
- Volume was 8.40M shares, 0.8x its 50-day average of 10.09M.
- Price is -0.5% vs its 50-day average ($143.14) and +15.1% vs its 200-day average ($123.69).
- 52-week range $82.01–$156.92; today's close sits at 81% of that range, 9.3% below the 52-week high.
Oct 7, 2026 — MRK rises 0.6% to $142.79
- Closed at $142.79, +0.60% vs the prior close of $141.94. Day range $141.49–$144.15, opened at $142.03.
- Volume was 6.35M shares, 0.6x its 50-day average of 10.17M.
- Price is -0.1% vs its 50-day average ($142.90) and +15.6% vs its 200-day average ($123.49).
- 52-week range $82.01–$156.92; today's close sits at 81% of that range, 9.0% below the 52-week high.
Oct 6, 2026 — MRK rises 1.7% to $141.94
- Closed at $141.94, +1.72% vs the prior close of $139.54. Day range $139.74–$142.16, opened at $140.13.
- Volume was 8.07M shares, 0.8x its 50-day average of 10.14M.
- Price is -0.5% vs its 50-day average ($142.68) and +15.1% vs its 200-day average ($123.28).
- 52-week range $82.01–$156.92; today's close sits at 80% of that range, 9.5% below the 52-week high.
Oct 5, 2026 — MRK slides 3.3% to $139.54, a 1-month low
- Closed at $139.54, -3.30% vs the prior close of $144.30. Day range $138.80–$144.06, opened at $143.67.
- Volume was 9.48M shares, 0.9x its 50-day average of 10.08M.
- Price is -2.0% vs its 50-day average ($142.46) and +13.4% vs its 200-day average ($123.06).
- 52-week range $82.01–$156.92; today's close sits at 77% of that range, 11.1% below the 52-week high.
Oct 2, 2026 — MRK rises 0.3% to $144.30
- Closed at $144.30, +0.34% vs the prior close of $143.81. Day range $142.73–$144.35, opened at $143.77.
- Volume was 9.66M shares, 1.0x its 50-day average of 10.06M.
- Price is +1.4% vs its 50-day average ($142.29) and +17.5% vs its 200-day average ($122.86).
- 52-week range $82.01–$156.92; today's close sits at 83% of that range, 8.0% below the 52-week high.
MRK latest news & SEC filings
Every SEC filing by or about MRK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Oct 13, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Guindo Chirfi sold 10,000 shares at $135.00 (≈$1.35M) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 7, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $16.61B (prior year $15.81B) (+5.1% vs Jun 30, 2025)
- Net income: -$1.33B (prior year $4.43B) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.54 (prior year $1.76) (loss widened vs Jun 30, 2025)
Aug 7, 2026 · 13F-HR — Quarterly holdings report filed by an institutional investment manager
Quarterly holdings report filed by an institutional investment manager
Aug 4, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 24, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Jun 24, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Jun 24, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade MRK
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 3, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.29% (largest 3.8%).
- Liquidity: about 10.20M shares (≈$1.48B) trade per day on average.
- 52-week position: $145.19 vs a range of $82.01–$156.92 (84% of the range).
- Dividends: last ex-dividend date Sep 15, 2026 ($0.85/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Chirfi Guindo sold 10,000 shares on Aug 13, 2026.
- Latest filings: 8-K Oct 13, 2026; 10-Q Aug 7, 2026; 8-K Aug 4, 2026.
- Share count: 2.47B shares outstanding (Jul 31, 2026), -1.2% vs a year earlier.
- Listing: NYSE · industry: Pharmaceutical Preparations.
MRK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 149.70 | 152.34 | 144.91 | 145.19 | 13.85M |
| Oct 14, 2026 | 143.10 | 148.16 | 142.66 | 147.37 | 9.80M |
| Oct 13, 2026 | 145.85 | 145.93 | 141.58 | 141.98 | 8.38M |
| Oct 12, 2026 | 145.75 | 146.36 | 144.64 | 145.45 | 8.02M |
| Oct 9, 2026 | 141.37 | 146.68 | 141.36 | 145.60 | 9.29M |
| Oct 8, 2026 | 141.90 | 142.77 | 138.89 | 142.38 | 8.40M |
| Oct 7, 2026 | 142.03 | 144.15 | 141.49 | 142.79 | 6.35M |
| Oct 6, 2026 | 140.13 | 142.16 | 139.74 | 141.94 | 8.07M |
| Oct 5, 2026 | 143.67 | 144.06 | 138.80 | 139.54 | 9.48M |
| Oct 2, 2026 | 143.77 | 144.35 | 142.73 | 144.30 | 9.66M |
| Oct 1, 2026 | 144.71 | 145.39 | 143.26 | 143.81 | 7.86M |
| Sep 30, 2026 | 148.95 | 149.27 | 145.26 | 145.31 | 10.22M |
| Sep 29, 2026 | 148.17 | 150.36 | 146.09 | 149.28 | 8.20M |
| Sep 28, 2026 | 147.65 | 149.19 | 146.28 | 148.69 | 7.70M |
| Sep 25, 2026 | 148.06 | 149.98 | 147.48 | 148.78 | 8.29M |
| Sep 24, 2026 | 148.17 | 151.46 | 147.90 | 147.98 | 10.31M |
| Sep 23, 2026 | 151.32 | 152.01 | 146.89 | 148.08 | 9.70M |
| Sep 22, 2026 | 148.69 | 153.57 | 148.04 | 150.91 | 11.17M |
| Sep 21, 2026 | 146.79 | 150.49 | 145.60 | 149.50 | 7.99M |
| Sep 18, 2026 | 147.08 | 147.84 | 145.74 | 146.87 | 31.16M |
About Merck
Merck (MRK) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in RAHWAY, NJ. State of incorporation: NJ. Fiscal year ends December 31. SEC CIK 310158.
MRK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Douglas M Jr Baker | Director | Jun 2, 2026 |
| Mary Ellen Coe | Director | Jul 1, 2026 |
| Pamela J. Craig | Director | Jun 2, 2026 |
| Robert M Davis | Chairman, CEO & President | May 7, 2026 |
| Thomas H Glocer | Director | Jun 2, 2026 |
| Surendralal Lanca Karsanbhai | Director | Jul 1, 2026 |
| Risa J Lavizzo-Mourey | Director | Jun 2, 2026 |
| Stephen Mayo | Director | Jun 2, 2026 |
| Patricia F Russo | Director | Jun 2, 2026 |
| Paul Rothman | Director | Jun 2, 2026 |
| Christine E Seidman | Director | Jul 1, 2026 |
| Inge G Thulin | Director | Jun 2, 2026 |
| Kathy J Warden | Director | Jun 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | May 1, 2026 |
| Robert M Davis | Chairman, CEO & President | May 7, 2026 |
| Richard R. Deluca | EVP&Pres, Merck Animal Heallth | Aug 12, 2026 |
| Cristal N Downing | Chief Comm. & Public Afrs Ofcr | Nov 12, 2025 |
| Brian Foard | EVP, Specialty, Pharma, & ID | May 7, 2026 |
| Chirfi Guindo | EVP, Access, Policy & Comms | Aug 13, 2026 |
| Gaurav K Gupta | EVP, CIDO | Sep 1, 2026 |
| Betty D Larson | EVP, Chief HR Officer | May 7, 2026 |
| Dean Y Li | Executive VP & President, MRL | May 7, 2026 |
| Caroline Litchfield | EVP & CFO | May 7, 2026 |
| David R. Maraldo | EVP & Pres. MMD | Aug 7, 2026 |
| Johannes Jacobus Oosthuizen | EVP, Oncology & Int?l | May 7, 2026 |
| Joseph Romanelli | President, Human Health Int?l | Jan 28, 2026 |
| Dalton E. Iii Smart | SVP Fin. - Global Controller | May 7, 2026 |
| David Michael Williams | EVP,Chief Info&Digital Officer | Aug 7, 2026 |
| Jennifer Zachary | EVP, General Counsel | Aug 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 13, 2026 | Chirfi Guindo | Sale | 10,000 | $135.00 |
| Aug 12, 2026 | Jennifer Zachary | Sale | 80,315 | $133.46 |
| Aug 12, 2026 | Richard R. Deluca | Sale | 11,099 | $131.61 |
| Aug 12, 2026 | Richard R. Deluca | Sale | 600 | $132.04 |
| Aug 11, 2026 | Richard R. Deluca | Sale | 7,410 | $131.33 |
| Aug 11, 2026 | Richard R. Deluca | Sale | 5,427 | $132.35 |
| Aug 10, 2026 | Richard R. Deluca | Sale | 20,784 | $130.43 |
| Aug 6, 2026 | Richard R. Deluca | Sale | 805 | $131.02 |
| Aug 6, 2026 | Richard R. Deluca | Sale | 300 | $131.02 |
| Aug 6, 2026 | Richard R. Deluca | Sale | 4,945 | $130.23 |
| Aug 6, 2026 | Chirfi Guindo | Sale | 15,000 | $131.00 |
| Aug 5, 2026 | David Michael Williams | Sale | 34,705 | $128.77 |
| Aug 5, 2026 | David Michael Williams | Sale | 4,600 | $128.77 |
| Aug 5, 2026 | David Michael Williams | Sale | 13,542 | $128.77 |
| Aug 5, 2026 | David R. Maraldo | Sale | 9,709 | $128.72 |
MRK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $65.01B | $18.25B | 7.28 | $16.47B |
| Dec 31, 2024 | $64.17B | $17.12B | 6.74 | $21.47B |
| Dec 31, 2023 | $60.12B | $365.00M | 0.14 | $13.01B |
| Dec 31, 2022 | $59.28B | $14.52B | 5.71 | $19.09B |
| Dec 31, 2021 | $48.70B | $13.05B | 5.14 | — |
Latest balance sheet: total assets $129.80B, total liabilities $—, cash $6.85B (as of Jun 30, 2026).
MRK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $128.00 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $109.18 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $115.84 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $86.28 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $82.63 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $79.84 |
| Feb 4, 2025 | 8-K Item 2.02 (results) | $90.74 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $102.32 |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
| Feb 1, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MRK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.